These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9480156)

  • 41. Improvement of blood component quality--automatic separation of blood components in a new bag system.
    Kretschmer V; Khan-Blouki K; Biermann E; Söhngen D; Eckle R
    Infusionstherapie; 1988 Dec; 15(6):232-9. PubMed ID: 3235201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of leukocyte-poor platelet concentrates from buffy coats. I. Special inserts for centrifuge cups.
    Pietersz RN; Reesink HW; Dekker WJ; Fijen FJ
    Vox Sang; 1987; 53(4):203-7. PubMed ID: 3439099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.
    Fernández-Muñoz H; Castilla-Llorente C; Plaza EM; Martínez-Millán C; Heras I; Iniesta P; Amigo ML; Ferrer-Marin F; Candela MJ; Lozano ML; Vicente V; Rivera J
    Blood Transfus; 2018 May; 16(3):273-278. PubMed ID: 28488971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates.
    Zhang JG; Carter CJ; Devine DV; Scammell K; Weiss S; Gyongyossy-Issa MI
    Vox Sang; 2008 May; 94(4):299-305. PubMed ID: 18179681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
    Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
    Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
    Gulliksson H; Sjödin A; Sandgren P; Vesterinen M; Larsson S; Diedrich B
    Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use and preparation of thrombocyte concentrates].
    Jovanović R; Erceg S; Rakić S
    Med Pregl; 1996; 49(7-8):301-4. PubMed ID: 8926948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preparation of leukocyte depleted thrombocytapheresis preparations using closed disposable systems with an in-line filter for the AS 104 cell separator].
    Moog R; Kalb R; Müller N; Köbke AC
    Beitr Infusionsther Transfusionsmed; 1997; 34():114-7. PubMed ID: 9417334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. White blood cell depletion of single-donor platelet preparations using the new adsorption filter biofil P 10 BBS.
    Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():55-7. PubMed ID: 9422101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Technical aspects of buffy coat removal from whole blood and those of platelet production from single buffy coat units.
    Rácz Z; Baróti C
    Biomed Tech (Berl); 1993 Nov; 38(11):266-9. PubMed ID: 8123765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
    Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
    Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet concentrates produced from whole blood using the Atreus processing system.
    Thomas S; Beard M; Garwood M; Callaert M; Cardigan R
    Vox Sang; 2009 Aug; 97(2):93-101. PubMed ID: 19392785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters.
    Meyer TP; Zehnter I; Hofmann B; Zaisserer J; Burkhart J; Rapp S; Weinauer F; Schmitz J; Illert WE
    J Immunol Methods; 2005 Dec; 307(1-2):150-66. PubMed ID: 16325197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Preparation of leukocyte-depleted human platelet concentrates by centrifugation and filtration of a pool of sterilely connected buffy-coats].
    Angué M; Chatelain P; Domy M; Guignier F; Richaud P
    Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):9-19. PubMed ID: 2015038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
    Posch U; Kokelj M; Kostner GM; Lanzer G
    Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of white blood cell fragments, during the preparation and storage of platelet concentrates, as measured by using real-time polymerase chain reaction.
    Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Huijgens PC; van der Meer PF; Reesink HW
    Vox Sang; 2004 Nov; 87(4):250-6. PubMed ID: 15585020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
    Albanyan AM; Harrison P; Murphy MF
    Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.